Alkaline Phosphatase (Tissue Non-Specific) antibody
GTX100817
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetALPL
Overview
- SupplierGeneTex
- Product NameAlkaline Phosphatase (Tissue Non-Specific) antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID249
- Target nameALPL
- Target descriptionalkaline phosphatase, biomineralization associated
- Target synonymsAP-TNAP, APTNAP, HOPS, HPPA, HPPC, HPPI, HPPO, TNALP, TNAP, TNS-ALP, TNSALP, alkaline phosphatase, tissue-nonspecific isozyme, alkaline phosphatase liver/bone/kidney isozyme, alkaline phosphatase, liver/bone/kidney, liver/bone/kidney-type alkaline phosphatase, phosphoamidase, phosphocreatine phosphatase, tissue non-specific alkaline phosphatase, tissue-nonspecific ALP
- HostRabbit
- IsotypeIgG
- Protein IDP05186
- Protein NameAlkaline phosphatase, tissue-nonspecific isozyme
- Scientific DescriptionThere are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. The exact physiological function of the alkaline phosphatases is not known. A proposed function of this form of the enzyme is matrix mineralization; however, mice that lack a functional form of this enzyme show normal skeletal development. This enzyme has been linked directly to hypophosphatasia, a disorder that is characterized by hypercalcemia and includes skeletal defects. The character of this disorder can vary, however, depending on the specific mutation since this determines age of onset and severity of symptoms. Alternatively spliced transcript variants, which encode the same protein, have been identified for this gene. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Bernabei I, Hansen U, Ehirchiou D, et al. CD11b Deficiency Favors Cartilage Calcification via Increased Matrix Vesicles, Apoptosis, and Lysyl Oxidase Activity. Int J Mol Sci. 2023,24(11). doi: 10.3390/ijms24119776Read this paper
- Kengelbach-Weigand A, Thielen C, Bäuerle T, et al. Personalized medicine for reconstruction of critical-size bone defects - a translational approach with customizable vascularized bone tissue. NPJ Regen Med. 2021,6(1):49. doi: 10.1038/s41536-021-00158-8Read this paper
- Yen YT, Chien M, Wu PY, et al. PP2A in LepR+ mesenchymal stem cells contributes to embryonic and postnatal endochondral ossification through Runx2 dephosphorylation. Commun Biol. 2021,4(1):658. doi: 10.1038/s42003-021-02175-1Read this paper
- Ou L, Wang H, Wu Z, et al. Effects of cadmium on osteoblast cell line: Exportin 1 accumulation, p-JNK activation, DNA damage and cell apoptosis. Ecotoxicol Environ Saf. 2021,208:111668. doi: 10.1016/j.ecoenv.2020.111668Read this paper
- Matoug-Elwerfelli M, Nazzal H, Raif EM, et al. Ex-vivo recellularisation and stem cell differentiation of a decellularised rat dental pulp matrix. Sci Rep. 2020,10(1):21553. doi: 10.1038/s41598-020-78477-xRead this paper
- Agustina H, Asyifa I, Aziz A, et al. The Role of Osteocalcin and Alkaline Phosphatase Immunohistochemistry in Osteosarcoma Diagnosis. Patholog Res Int. 2018,2018:6346409. doi: 10.1155/2018/6346409Read this paper
- Wang JY, Chen WM, Wen CS, et al. Du-Huo-Ji-Sheng-Tang and its active component Ligusticum chuanxiong promote osteogenic differentiation and decrease the aging process of human mesenchymal stem cells. J Ethnopharmacol. 2017,198:64-72. doi: 10.1016/j.jep.2016.12.011Read this paper
- Weigand A, Beier JP, Schmid R, et al. Bone Tissue Engineering Under Xenogeneic-Free Conditions in a Large Animal Model as a Basis for Early Clinical Applicability. Tissue Eng Part A. 2017,23(5-6):208-222. doi: 10.1089/ten.TEA.2016.0176Read this paper
- Boos AM, Weigand A, Deschler G, et al. Autologous serum improves bone formation in a primary stable silica-embedded nanohydroxyapatite bone substitute in combination with mesenchymal stem cells and rhBMP-2 in the sheep model. Int J Nanomedicine. 2014,9:5317-39. doi: 10.2147/IJN.S66867Read this paper
- Greenbaum AM, Revollo LD, Woloszynek JR, et al. N-cadherin in osteolineage cells is not required for maintenance of hematopoietic stem cells. Blood. 2012,120(2):295-302. doi: 10.1182/blood-2011-09-377457Read this paper
![IHC-P analysis of human testicular carcinoma tissue using GTX34402 Alkaline Phosphatase (Tissue Non-Specific) antibody [ALPL/597].](https://www.genetex.com/upload/website/prouct_img/normal/GTX34402/GTX34402_20200115_IHC-P_1185_w_23060801_154.webp)


